Patents by Inventor Anthony Hart

Anthony Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090142351
    Abstract: A novel gene PGC-3, and its role in regulating the transcriptional activity of PPAR? in adipose tissue. PGC-3 is highly expressed in human white adipose tissue and has utility in the development of new therapeutic agents for use in the treatment of obesity and other related disorders such as non-insulin dependent diabetes mellitus, insulin resistance syndrome, dyslipidemia, and atherosclerosis.
    Type: Application
    Filed: October 29, 2007
    Publication date: June 4, 2009
    Applicant: AstraZeneca AB
    Inventors: Kevin Anthony Hart, Carl Thomas Montague, Antonio Vidal-Puig
  • Publication number: 20090119923
    Abstract: A safety razor has a handle and a cartridge selectively detachable from the handle. The cartridge has at least one blade with a sharp cutting edge and a beginning shaving utility. A connecting is coupled to the handle for attaching or detaching the cartridge from the handle in response to an action. The safety razor includes a sensor that generates a signal in response to the action.
    Type: Application
    Filed: September 11, 2008
    Publication date: May 14, 2009
    Inventors: Robert Anthony Hart, Matthias Gester, Hannah Bryony Mantle
  • Publication number: 20090071010
    Abstract: A powered wet razor has a handle and a cartridge selectively detachable from the handle. The cartridge has at least one blade with a sharp cutting edge and is characterized by an expected shaving utility. An electrical arrangement that detects and tracks utility of the razor and determines a remaining shaving utility based on the expected utility and the tracked utility. The razor includes an indicator for providing a remaining shaving utility signal to a user.
    Type: Application
    Filed: September 11, 2008
    Publication date: March 19, 2009
    Inventor: Robert Anthony Hart
  • Publication number: 20090071008
    Abstract: A safety razor has a handle and a cartridge selectively detachable from the handle. The cartridge has at least one blade with a sharp cutting edge and an expected shaving utility. A connecting structure is coupled to the handle and attaches or detaches the cartridge from the handle in response to a detachment action performed by a user. A detector within the handle has an actuator coupled to the connecting structure and a sensor for generating a signal, wherein the actuator applies an action on the sensor during the action and the sensor generates the signal in response to the action.
    Type: Application
    Filed: September 11, 2008
    Publication date: March 19, 2009
    Inventors: Robert Anthony Hart, Matthias Gester, Hannah Bryony Mantle
  • Publication number: 20080189953
    Abstract: A safety razor has a blade unit having at least one blade with a sharp cutting edge. A dielectric handle is configured to carry the blade unit and a conductive ground member is disposed within the handle. The safety razor has an electrically operated device. An electrical arrangement having a sensor electrically coupled to the blade unit and the ground member senses skin contact with the blade unit and actuates the device based on the sensing.
    Type: Application
    Filed: May 3, 2007
    Publication date: August 14, 2008
    Inventors: Paul Michael Jessemey, Roy Nicoll, Robert Anthony Hart
  • Patent number: 7306922
    Abstract: A novel gene PGC-3, and its role in regulating the transcriptional activity of PPAR? in adipose tissue. PGC-3 is highly expressed in human white adipose tissue and has utility in the development of new therapeutic agents for use in the treatment of obesity and other related disorders such as non-insulin dependent diabetes mellitus, insulin resistance syndrome, dyslipidemia, and atherosclerosis.
    Type: Grant
    Filed: September 12, 2001
    Date of Patent: December 11, 2007
    Assignee: AstraZeneca AB
    Inventors: Kevin Anthony Hart, Carl Thomas Montague, Antonio Vidal-Puig
  • Publication number: 20060140911
    Abstract: The present invention provides a composition for treating a bacterial biofilm, comprising a first bacteriophage that is capable of infecting a bacterium within said biofilm, and a first polysaccharide lyase enzyme that is capable of degrading a polysaccharide within said biofilm. The composition preferably further comprises a pharmaceutically-acceptable antimicrobial agent, and may also include a DNase. Also provided are modified bacteriophages, methods of creating modified bacteriophages, use of said compositions and bacteriophage for treating biofilms, and methods for treating biofilms using the bacteriophages and compositions of the invention.
    Type: Application
    Filed: January 12, 2004
    Publication date: June 29, 2006
    Applicant: Health Protection Agency
    Inventors: Richard Sharp, Gavin Hughes, Anthony Hart, James Walker
  • Publication number: 20040093627
    Abstract: The use of the G protein coupled receptor GPR56 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: May 13, 2004
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Publication number: 20040093626
    Abstract: The use of the G protein coupled receptor GPR3 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: May 13, 2004
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Publication number: 20040077536
    Abstract: A gene PGC-3 PPAR gamma coactivator-3, and it's role in regulating the transcriptional activity of peroxisome proliferator activated receptor-Y PPAR-Y in adipose tissue. PGC-3 is highly expressed in human white adipose tissue and has utility in the development of new therapeutic agents for use in the treatement of obesity and other related disorders such as non-insulin dependent diabetes mellitus, insulin resistance syndrome, dyslipidemia, and atherosclerosis.
    Type: Application
    Filed: March 13, 2003
    Publication date: April 22, 2004
    Inventors: Kevin Anthony Hart, Carl Thomas Montague, Antonio Vidal-Puig
  • Publication number: 20040053812
    Abstract: The use of the G protein coupled receptor GPR22 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 18, 2004
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Publication number: 20020082412
    Abstract: The use of the G protein coupled receptor GPR3 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: May 2, 2001
    Publication date: June 27, 2002
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Publication number: 20020040132
    Abstract: The use of the G protein coupled receptor GPR56 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: May 2, 2001
    Publication date: April 4, 2002
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Patent number: 6165773
    Abstract: Methods for preserving micro-organisms including viruses, such that infectivity is retained, are provided, as well as the use of such methods in preparing e.g. vaccines.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: December 26, 2000
    Assignee: Provalis UK Limited
    Inventors: Roger Randal Charles New, Charles Anthony Hart